• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

45
12
6
6
4

COUNTRY

12
1
1
1
1

CATEGORIES

  • 40
  • 20
  • 18
  • 13
  • 11
  • 10
  • 9
  • 7
  • 5
  • 5
  • 4
  • 3
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
SHOW ALL…

PRICE

33
59
65
114

PUBLISHED

9
10
26
114

PRODUCT TYPE

67
26
19
1
1

Search "Clinical Management of Ovarian Cancer" returned 114 results.

PRODUCT TITLE
Oncology Intelligence: A Comprehensive Report for Decision Making Oncology Intelligence: A Comprehensive Report for Decision Making - Product Thumbnail Image

Oncology Intelligence: A Comprehensive Report for Decision Making

Oncology Intelligence Report 2013 provides complete landscape on cancer drug development, by bringing more authentic data under evaluation and is designed in a manner to keep knowledge instant, clear...

January 2013

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020

Ovarian Cancer Therapeutics - Global Drug Forecasts and Treatment Analysis 2020 Summary GlobalData, the industry analysis specialist, has released its new report, “Ovarian Cancer Therapeutics - Global...

February 2012
FROM
Drug Delivery in Cancer - Technologies, Markets and Companies Drug Delivery in Cancer - Technologies, Markets and Companies - Product Thumbnail Image

Drug Delivery in Cancer - Technologies, Markets and Companies

Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed worldwide each year and considerable research is in progress for drug discovery...

December 2014
FROM

Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology

GBI Research, the leading business intelligence provider, has released its latest research, “Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan...

November 2011
FROM
Personalized Medicine - Scientific and Commercial Aspects Personalized Medicine - Scientific and Commercial Aspects - Product Thumbnail Image

Personalized Medicine - Scientific and Commercial Aspects

The aim of personalized medicine or individualized treatment is to match the right drug to the right patient and, in some cases, even to design the appropriate treatment for a patient according to his/her...

December 2014
FROM

Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers to Drive Drug Development

GBI Research, the leading business intelligence provider, has released its latest research, “Oncology Therapeutics Market to 2017 - High Unmet Need in the Management and Treatment of Metastatic Cancers...

December 2011
FROM

Novel cancer-related biomarkers Volume 2

Aims and Scope Various KLK proteins and their encoding genes have attracted increased attention among scientists and clinicians worldwide since they represent very interesting and functionally distinct...

December 2012
FROM
Biomarkers - Technologies, Markets and Companies Biomarkers - Technologies, Markets and Companies - Product Thumbnail Image

Biomarkers - Technologies, Markets and Companies

This report follows the broad definition of a biomarker as a characteristic that can be objectively measured and evaluated as an indicator of normal biological or pathogenic processes as well as pharmacological...

December 2014
FROM
The Top 70 Western European Oncology Contract Research Organisations The Top 70 Western European Oncology Contract Research Organisations - Product Thumbnail Image

The Top 70 Western European Oncology Contract Research Organisations

It is estimated that clinical development expenditures outsourced by pharmaceutical, medical device and biotechnology companies worldwide in 2012 was approximately Euro 20 6 billion With greatly developed...

July 2013
FROM

Cancer Diagnostic Testing World Markets

Cancer testing is one of the most important growth opportunities for the next three to five years in the diagnostics segment The National Cancer Institute estimates that about ten million Americans...

May 2013
FROM
Gene Therapy - Technologies, Markets and Companies Gene Therapy - Technologies, Markets and Companies - Product Thumbnail Image

Gene Therapy - Technologies, Markets and Companies

Gene therapy can be broadly defined as the transfer of defined genetic material to specific target cells of a patient for the ultimate purpose of preventing or altering a particular disease state. Genes...

December 2014
FROM

Neogenix Oncology, Inc. - Product Pipeline Analysis

Summary Neogenix Oncology, Inc. (NOI) is a clinical stage biotechnology company, based in the US. The company develops therapeutic and diagnostic products for the early detection and treatment of cancer....

November 2012
FROM
The Cancer Market Outlook to 2016 The Cancer Market Outlook to 2016 - Product Thumbnail Image

The Cancer Market Outlook to 2016

The global cancer market is becoming increasingly competitive, with two therapeutic classes, namely antineoplastics and cytostatic hormonal treatments, dominating this sector This report presents leading...

June 2011
FROM

Target Discovery, Inc. - Product Pipeline Analysis

Summary Target Discovery, Inc. (TDI) is a medical equipment manufacturing company, based in the US. The company discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and...

November 2012
FROM
DNA Sequencing - Technologies, Markets and Companies DNA Sequencing - Technologies, Markets and Companies - Product Thumbnail Image

DNA Sequencing - Technologies, Markets and Companies

This report briefly reviews basics of human genome variations, development of sequencing technologies, and their applications. Current large and small sequencers are described as well as companies developing...

December 2014
FROM

Cancer Bundle

The Cancer Bundle offers a 15% discount off the total transaction price for the following reports being purchased simultaneously: - Biomarker Technology Platforms for Cancer Diagnoses and Therapies...

May 2012
FROM

Personalized Medicine - A Strategic Analysis of Industry Trends, Technologies, Participants and Environment

“Personalized Medicine- A Strategic Analysis of Industry Trends, Technologies, Participants, and Environment” provides you with a comprehensive account of the market size, segmentation, key players,...

May 2013
FROM
Molecular Diagnostics - Technologies, Markets and Companies Molecular Diagnostics - Technologies, Markets and Companies - Product Thumbnail Image

Molecular Diagnostics - Technologies, Markets and Companies

This report describes and evaluates the molecular diagnostics technologies that will play an important role in practice of medicine, public health, pharmaceutical industry, forensics and biological...

December 2014
FROM
Ovarian Cancer Drug Pipeline Update 2014 Ovarian Cancer Drug Pipeline Update 2014 - Product Thumbnail Image

Ovarian Cancer Drug Pipeline Update 2014

With nearly 60,000 cases of ovarian cancer being diagnosed in the seven major markets each year, this cancer type is by no means small and therefore it remains an important secondary indication for...

October 2014
FROM

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis

Summary Rosetta Genomics, Ltd. (RGL) is a medical device company, based in Israel. The company develops and commercializes new diagnostic and therapeutic products based on group of genes known as microRNAs....

November 2012
FROM
Loading Indicator

Our Clients

Our clients' logos